Brazil Supreme Court justice orders house arrest of former president Bolsonaro
Justice Alexandre de Moraes said in his decision that the right-wing firebrand did not comply with judicial restraining orders imposed on him last month.
Moraes also banned Bolsonaro from receiving visits, with exceptions for lawyers and people authorized by the court, and use of a cell phone either directly or through third parties.
The restrictions on Bolsonaro were imposed over allegations that he courted the interference of Trump, who recently tied steep new tariffs on Brazilian goods to what he called a "witch hunt" against Bolsonaro.
The former Brazilian leader is facing charges that he conspired with dozens of his allies to overturn his 2022 electoral loss.
Bolsonaro's press representative confirmed the house arrest order and restrictions on using a cell phone.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
12 minutes ago
- Bloomberg
Brazil Plans Cheap Credit, Debt Delays for Firms Hit by Tariffs
Brazil is finalizing proposals to help companies mitigate the effects of steep US tariffs with debt extensions, cheaper credit and support for workers' salaries, according to an official with knowledge of the plans. The package is the cornerstone of President Luiz Inacio Lula da Silva's efforts to counteract the 50% tariffs Donald Trump threatened to impose on Brazilian goods, and will target relief at sectors that weren't among the nearly 700 exemptions the US leader outlined last week.
Politico
15 minutes ago
- Politico
Will feds weigh in on religious vax carveouts?
Driving the Day RELIGIOUS VAX EXEMPTIONS — It's back-to-school season, which means parents are shuttling their kids to pediatricians for annual checkups — and advocates for and against states' exemptions to vaccine mandates for school entry are gearing up for a fight, Lauren reports. Vaccine skeptics have sought to make their case to the Trump administration's Religious Liberty Commission — created by executive order in May — for executive action to bolster religious carve-outs. But they face pushback from public health experts who warn that more exemptions could threaten public health, setting up another front in the vaccine wars. Four states — California, Connecticut, Maine and New York — don't offer religious exemptions to school vaccine requirements, and Massachusetts lawmakers are considering banning them. West Virginia provides exemptions after GOP Gov. Patrick Morrisey signed an executive order earlier this year invoking the state's religious freedom law. Some religious liberty groups have called on the federal government — which has no say in state vaccine mandates — to use federal education funding as leverage to expand religious opt-outs from school immunization requirements, pointing to a Clinton-era religious protection statute. Precedential web: Some vaccine law experts question how far the executive branch could go to nudge those outlier states toward accepting religious exemptions. The Supreme Court curtailed the Religious Freedom Restoration Act's application to the states in 1997, and administrative conditions on federal funding can't run afoul of Congress' directions. But proponents say those lawyers ignore more recent opinions that work in exemption advocates' favor, pointing to a Covid-19-era decision lifting in-home gathering restrictions on religious grounds and, more recently, the court's ruling in favor of parents who want to opt their children out of LGBTQ+-themed lessons in public schools. Shifting winds: The number of kindergarteners entering school with at least one vaccine exemption continues to tick up, with the CDC reporting last week that 3.6 percent had one in the 2024-2025 school year, compared with 2.2 percent a decade ago. Days before the updated data was released, the American Academy of Pediatrics reaffirmed its opposition to religious exemptions, arguing they should be abolished to protect public health. 'In practice, nonmedical exceptions based on religious belief can substantially limit the public health value of vaccine requirements for school attendance,' the group said in a statement. 'There is no practicable way for schools or other involved community partners to distinguish fairly among religious or other nonmedical claims.' What's next: The Religious Liberty Commission will hold a hearing next month on public education issues, giving exemption proponents another opening to make their case. It's unclear where the White House stands on the concept — a spokesperson didn't comment — but the first Trump administration's HHS pursued avenues to grant health care workers expanded 'conscience' protections and to allow imports of certain vaccines due to some patients' religious beliefs. IT'S TUESDAY. WELCOME BACK TO PRESCRIPTION PULSE. Your host is wondering whether concerns about a common allergy medicine's risks might catch the FDA's attention. Send tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). Eye on the FDA NEW TOP LAWYER — FDA Commissioner Marty Makary named a longtime government attorney on Monday to be the agency's chief counsel, months after his first pick was torpedoed by Sen. Josh Hawley (R-Mo.). Sean Keveney, who most recently served as HHS's acting general counsel, served as a career civil servant at DOJ's civil rights division before becoming deputy general counsel at HHS in 2019, according to the department and his LinkedIn profile. His predecessor in the position, Hilary Perkins, was also a career DOJ lawyer whose appointment drew Hawley's ire before Makary's confirmation because of her record defending the Biden administration's abortion pill policies. While Perkins also defended the Trump FDA's mifepristone positions, that wasn't enough to overcome his opposition, and she ultimately stepped down days into the job. MDUFA KICKOFF — The FDA's medical device user fee program is not set to expire until Sept. 30, 2027, but the process to renew it has already begun. Despite HHS Secretary Robert F. Kennedy Jr.'s vocal distaste for the user fee programs, the Trump administration has made it clear they are committed to the monthslong process that will likely result in their renewal for another five years. Industry and FDA leaders — including FDA Commissioner Marty Makary and Center for Devices and Radiological Health Director Michelle Tarver — met Monday to discuss the potential sixth iteration of the medical device user fee program. 'While user fees support timeliness and predictability by providing FDA with additional resources, user fees are not a guarantee of approval,' AdvaMed's senior executive vice president, Janet Trunzo, said according to prepared remarks. 'They never have been, and they never should be.' In Congress SENATE PASSES FDA FUNDING — Before leaving town for the August recess, the Senate passed a bill to fund the FDA for fiscal 2026 as part of a minibus package by an 87-9 vote. The legislation, which funds the agency at $7 billion, is made up of $3.6 billion in taxpayer funds and $3.4 billion in user fee revenues. But it is unclear whether lawmakers will have to turn to a continuing resolution before government funding runs out at the end of September. The House Appropriations Committee previously advanced an FDA bill that funded the agency at a lower level. Research Corner BOOST FOR WOMEN'S HEALTH — The Gates Foundation said Monday it would spend $2.5 billion through 2030 to speed global women's research into maternal, menstrual, gynecological and sexual health. Pharma Moves Erika Sward is now chief advocacy officer at UsAgainstAlzheimer's. She previously was assistant vice president of national advocacy at the American Lung Association. Document Drawer FDA Commissioner Marty Makary met with Rep. John Joyce (R-Pa.) for an introductory meeting on July 24. He also met with People for the Ethical Treatment of Animals to discuss nonanimal testing approaches on July 21, according to newly posted public calendar disclosures. He also met with the leadership team of the Government Accountability Office on July 16 to discuss 'items of mutual interest.' WHAT WE'RE READING Top FDA cancer medicine regulator Richard Pazdur played a critical role in the rejection of Replimune Group's skin cancer therapy, STAT's Adam Feuerstein reports. Longevity companies are eyeing Montana as a potential hub for 'biohacking' treatments thanks to state laws embracing patients' 'right-to-try' experimental drugs, The Wall Street Journal's Alex Janin writes.
New York Times
15 minutes ago
- New York Times
Columbia and Brown to Disclose Admissions and Race Data in Trump Deal
As part of the settlements struck with two Ivy League universities in recent weeks, the Trump administration will gain access to the standardized test scores and grade point averages of all applicants, including information about their race, a measure that could profoundly alter competitive college admissions. That aspect of the agreements with Columbia and Brown, which goes well beyond the information typically provided to the government, was largely overlooked amid splashier news that the universities had promised to pay tens of millions of dollars to settle claims of violations of federal anti-discrimination laws, including accusations that they had tolerated antisemitism. The release of such data has been on the wish list of conservatives who are searching for evidence that universities are dodging a 2023 Supreme Court decision barring the consideration of race in college admissions, and will probably be sought in the future from many more of them. But college officials and experts who support using factors beyond test scores worry that the government — or private groups or individuals — will use the data to file new discrimination charges against universities and threaten their federal funding. The Trump administration is using every lever it can to push elite college admissions offices toward what it regards as 'merit-based' processes that more heavily weigh grades and test scores, arguing that softer measures, such as asking applicants about their life challenges or considering where they live, may be illegal proxies for considering race. The additional scrutiny is likely to resonate in admissions offices nationwide. It could cause some universities to reconsider techniques like recruitment efforts focused on high schools whose students are predominantly people of color, or accepting students who have outstanding qualifications in some areas but subpar test scores, even if they believe such actions are legal. Want all of The Times? Subscribe.
